OR2M3
gene geneOn this page
Also known as OST003
Summary
OR2M3 (olfactory receptor family 2 subfamily M member 3, HGNC:8269) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2M3 (Q8NG83). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 127062 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 66 total
- MANE Select transcript:
NM_001004689
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8269 |
| Approved symbol | OR2M3 |
| Name | olfactory receptor family 2 subfamily M member 3 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OST003 |
| Ensembl gene | ENSG00000228198 |
| Ensembl biotype | protein_coding |
| Entrez | 127062 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000456743, ENST00000641626
RefSeq mRNA: 1 — MANE Select: NM_001004689
NM_001004689
CCDS: CCDS31107
Canonical transcript exons
ENST00000641626 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811679 | 248197265 | 248197301 |
| ENSE00003812478 | 248203050 | 248212925 |
Expression profiles
Bgee: expression breadth broad, 13 present calls, max score 55.09.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 55.09 | gold quality |
| transverse colon | UBERON:0001157 | 48.70 | gold quality |
| sural nerve | UBERON:0015488 | 48.25 | silver quality |
| stromal cell of endometrium | CL:0002255 | 47.67 | gold quality |
| rectum | UBERON:0001052 | 46.60 | gold quality |
| endometrium | UBERON:0001295 | 45.96 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.22 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 44.58 | gold quality |
| cortex of kidney | UBERON:0001225 | 42.63 | silver quality |
| calcaneal tendon | UBERON:0003701 | 41.27 | gold quality |
| colon | UBERON:0001155 | 41.18 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 41.00 | gold quality |
| liver | UBERON:0002107 | 40.88 | gold quality |
| monocyte | CL:0000576 | 40.58 | gold quality |
| vermiform appendix | UBERON:0001154 | 40.12 | gold quality |
| leukocyte | CL:0000738 | 39.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 39.34 | silver quality |
| primary visual cortex | UBERON:0002436 | 39.05 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 38.82 | gold quality |
| muscle tissue | UBERON:0002385 | 38.46 | gold quality |
| intestine | UBERON:0000160 | 38.24 | gold quality |
| bone marrow | UBERON:0002371 | 38.09 | gold quality |
| bone marrow cell | CL:0002092 | 38.06 | gold quality |
| lymph node | UBERON:0000029 | 37.75 | gold quality |
| right lobe of liver | UBERON:0001114 | 37.34 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 37.19 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| tonsil | UBERON:0002372 | 36.27 | gold quality |
| blood | UBERON:0000178 | 35.76 | gold quality |
| metanephros cortex | UBERON:0010533 | 35.56 | silver quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-97 | yes | 2652.09 |
| E-MTAB-6678 | yes | 1708.36 |
| E-MTAB-5061 | yes | 14.72 |
| E-ANND-3 | yes | 5.22 |
| E-ENAD-20 | no | 63.53 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- This work shows that the specific thiol function of human OR2M3 is modulated by copper ions. The homology modeling/docking studies together with receptor functional expression studies suggest that this copper sensitivity is mediated by two copper-binding sites within narrowly tuned OR2M3. (PMID:31435697)
Cross-species orthologs
0 orthologs
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2M3 — Q8NG83 (reviewed: Q8NG83)
Alternative names: Olfactory receptor 2M6, Olfactory receptor OR1-54
All UniProt accessions (2): Q8NG83, A0A126GV67
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001004689* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NG83-F1 | 85.00 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
140 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2M3 | IGHV3-72 | A0A0B4J1Y9 | 418 |
| OR2M3 | RAX2 | Q96IS3 | 396 |
| OR2M3 | BDH2 | Q9BUT1 | 349 |
| OR2M3 | YPEL4 | Q96NS1 | 349 |
| OR2M3 | NKAPL | Q5M9Q1 | 339 |
| OR2M3 | IGHV3-15 | A0A0B4J1V0 | 334 |
| OR2M3 | IGHV3-11 | P01762 | 322 |
| OR2M3 | S100A13 | Q99584 | 315 |
| OR2M3 | CRLF1 | O75462 | 312 |
| OR2M3 | BCL6B | Q8N143 | 311 |
| OR2M3 | DDX19A | Q9NUU7 | 300 |
| OR2M3 | THSD7B | Q9C0I4 | 300 |
| OR2M3 | SGSM2 | O43147 | 297 |
| OR2M3 | TAS2R1 | Q9NYW7 | 284 |
| OR2M3 | ADM2 | Q7Z4H4 | 284 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A3KFT3, P0C628, P34982, P34985, P37068, P37071, Q15612, Q60879, Q8N146, Q8N162, Q8N349, Q8NG80, Q8NG81, Q8NG83, Q8NG85, Q8NG92, Q8NG95, Q8NGA1, Q8NGC7, Q8NGC8, Q8NGC9, Q8NGE0, Q8NGG4, Q8NGI8, Q8NGQ6, Q8NGS4, Q8NGY6, Q8NGY9, Q8NGZ0, Q8NGZ9, Q8NH16, Q8NH74, Q8NHA4, Q8NHB7, Q8NHC8, Q8VEX5, Q8VFR8, Q8VFV4, Q8VFX2, Q8VGI4
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
241 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:248203703:A:AG | acceptor_gain | 0.7900 |
| 1:248203704:A:G | acceptor_gain | 0.6900 |
| 1:248204000:A:T | donor_gain | 0.6500 |
| 1:248203808:G:GA | donor_gain | 0.6200 |
| 1:248203076:G:GT | donor_gain | 0.6100 |
| 1:248203677:AT:A | donor_gain | 0.6100 |
| 1:248203991:C:T | donor_gain | 0.6100 |
| 1:248203710:ATT:A | acceptor_gain | 0.5800 |
| 1:248203334:C:T | donor_gain | 0.5700 |
| 1:248203804:T:A | acceptor_gain | 0.5600 |
| 1:248203721:T:G | acceptor_gain | 0.5500 |
| 1:248203355:T:TA | donor_gain | 0.5400 |
| 1:248203700:T:A | acceptor_gain | 0.5400 |
| 1:248203710:A:AG | acceptor_gain | 0.5300 |
| 1:248203766:T:TA | donor_gain | 0.5300 |
| 1:248203534:G:GT | donor_gain | 0.5100 |
| 1:248203712:T:TA | acceptor_gain | 0.5100 |
| 1:248203939:GC:G | acceptor_gain | 0.5100 |
| 1:248203984:G:GT | donor_gain | 0.5100 |
| 1:248203938:A:AG | acceptor_gain | 0.5000 |
| 1:248203939:G:GG | acceptor_gain | 0.5000 |
| 1:248203333:G:GG | donor_gain | 0.4900 |
| 1:248203707:A:AG | acceptor_gain | 0.4900 |
| 1:248203874:A:AG | acceptor_gain | 0.4900 |
| 1:248203932:A:AG | acceptor_gain | 0.4900 |
| 1:248203332:A:AG | donor_gain | 0.4800 |
| 1:248203679:A:AG | acceptor_gain | 0.4800 |
| 1:248203680:G:GG | acceptor_gain | 0.4800 |
| 1:248203683:A:AG | donor_gain | 0.4800 |
| 1:248203720:AT:A | acceptor_gain | 0.4800 |
AlphaMissense
2055 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:248203938:A:C | S291R | 0.920 |
| 1:248203940:C:A | S291R | 0.920 |
| 1:248203940:C:G | S291R | 0.920 |
| 1:248203101:T:C | F12L | 0.904 |
| 1:248203103:C:A | F12L | 0.904 |
| 1:248203103:C:G | F12L | 0.904 |
| 1:248203596:T:C | F177L | 0.888 |
| 1:248203598:C:A | F177L | 0.888 |
| 1:248203598:C:G | F177L | 0.888 |
| 1:248203421:G:A | M118I | 0.876 |
| 1:248203421:G:C | M118I | 0.876 |
| 1:248203421:G:T | M118I | 0.876 |
| 1:248203432:G:C | R122P | 0.856 |
| 1:248203602:T:A | C179S | 0.852 |
| 1:248203603:G:C | C179S | 0.852 |
| 1:248203119:T:C | F18L | 0.850 |
| 1:248203121:C:A | F18L | 0.850 |
| 1:248203121:C:G | F18L | 0.850 |
| 1:248203170:T:C | F35L | 0.827 |
| 1:248203172:T:A | F35L | 0.827 |
| 1:248203172:T:G | F35L | 0.827 |
| 1:248203102:T:C | F12S | 0.826 |
| 1:248203356:T:A | C97S | 0.825 |
| 1:248203357:G:C | C97S | 0.825 |
| 1:248203512:T:A | W149R | 0.824 |
| 1:248203512:T:C | W149R | 0.824 |
| 1:248203603:G:A | C179Y | 0.824 |
| 1:248203599:T:C | F178L | 0.823 |
| 1:248203601:C:A | F178L | 0.823 |
| 1:248203601:C:G | F178L | 0.823 |
dbSNP variants (sampled 300 via entrez): RS1000162512 (1:248212574 GT>G,GTT,GTTTTTTT), RS1000187836 (1:248213362 A>G), RS1000224649 (1:248210171 A>G), RS1000276926 (1:248210346 G>T), RS1000446157 (1:248195526 A>G), RS1000538701 (1:248200175 G>A), RS1000775932 (1:248208041 C>T), RS1000814448 (1:248205411 C>G,T), RS1001119110 (1:248205109 A>G), RS1001174024 (1:248202442 A>G), RS1001336614 (1:248197925 ATC>A), RS1001439206 (1:248207774 A>G), RS1001479296 (1:248198511 C>G), RS1001656900 (1:248208589 C>G,T), RS1001713903 (1:248203225 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases mutagenesis, affects methylation, increases methylation | 2 |
| butyraldehyde | decreases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Endosulfan | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.